Published in Mar Drugs on July 26, 2017
Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature (2006) 5.54
Vaccine adjuvants: putting innate immunity to work. Immunity (2010) 5.02
Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol (2000) 2.99
Vaccines against intracellular infections requiring cellular immunity. Nature (2000) 2.20
Advances in vaccine adjuvants. Nat Biotechnol (1999) 2.18
A review of porcine circovirus 2-associated syndromes and diseases. Vet J (2005) 2.10
Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules (2011) 1.79
Vaccine adjuvants revisited. Vaccine (2007) 1.69
Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs (2010) 1.69
Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res (2004) 1.41
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J Biol Chem (2007) 1.23
A validated 1H NMR method for the determination of the degree of deacetylation of chitosan. J Pharm Biomed Anal (2003) 1.16
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol (2013) 1.14
Commercial porcine circovirus type 2 vaccines: efficacy and clinical application. Vet J (2012) 1.06
Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England - an economic disease model. Prev Vet Med (2013) 0.98
Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen. J Control Release (2010) 0.97
Acute phase response in porcine reproductive and respiratory syndrome virus infection. Comp Immunol Microbiol Infect Dis (2009) 0.92
Best practice and future challenges for vaccination against porcine circovirus type 2. Expert Rev Vaccines (2014) 0.91
N-acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro. Biochem Biophys Res Commun (2007) 0.91
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc Natl Acad Sci U S A (2013) 0.91
Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines. Vaccine (2014) 0.88
Preparation of chitooligosaccharides from chitosan by a complex enzyme. Carbohydr Res (1999) 0.87
Effects of chitosan on xenograft models of melanoma in C57BL/6 mice and hepatoma formation in SCID mice. Anticancer Res (2013) 0.85
The levels of PCV2 specific antibodies and viremia in pigs. Res Vet Sci (2007) 0.84
Chitooligosaccharides in combination with interferon-gamma increase nitric oxide production via nuclear factor-kappaB activation in murine RAW264.7 macrophages. Food Chem Toxicol (2006) 0.84
Role of mannose receptor in oligochitosan-mediated stimulation of macrophage function. Int Immunopharmacol (2005) 0.84
Kinetic and stoichiometric analysis of the modification process for N-terminal PEGylation of staphylokinase. Anal Biochem (2010) 0.83
Effect of chitooligosaccharides with different degrees of acetylation on wheat seedlings under salt stress. Carbohydr Polym (2015) 0.82
Inhibition of angiogenesis by chitooligosaccharides with specific degrees of acetylation and polymerization. Carbohydr Polym (2012) 0.82
A comparison study on the interactions of two oligosaccharides with tobacco cells by time-resolved fluorometric method. Carbohydr Polym (2012) 0.81
Propylbenzmethylation at Val-1(α) markedly increases the tetramer stability of the PEGylated hemoglobin: a comparison with propylation at Val-1(α). Biochim Biophys Acta (2012) 0.80
A solid-phase adsorption method for PEGylation of human serum albumin and staphylokinase: preparation, purification and biochemical characterization. Biotechnol Lett (2009) 0.80
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs. Drug Saf (2015) 0.79
Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus. Autoimmunity (2014) 0.79
Potent Antigen-Adjuvant Delivery System by Conjugation of Mycobacterium tuberculosis Ag85B-HspX Fusion Protein with Arabinogalactan-Poly(I:C) Conjugate. Bioconjug Chem (2016) 0.79
Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine. Vaccine (2015) 0.79
Efficacy of chitosan oligosaccharide as aquatic adjuvant administrated with a formalin-inactivated Vibrio anguillarum vaccine. Fish Shellfish Immunol (2015) 0.78
Enhanced immune response to inactivated porcine circovirus type 2 (PCV2) vaccine by conjugation of chitosan oligosaccharides. Carbohydr Polym (2017) 0.78